Ubillos, Itziar
Ayestaran, Aintzane
Nhabomba, Augusto J
Dosoo, David
Vidal, Marta
Jiménez, Alfons
Jairoce, Chenjerai
Sanz, Hèctor
Aguilar, Ruth
Williams, Nana Aba
Díez-Padrisa, Núria
Mpina, Maximilian
Sorgho, Hermann
Agnandji, Selidji Todagbe
Kariuki, Simon
Mordmüller, Benjamin
Daubenberger, Claudia
Asante, Kwaku Poku
Owusu-Agyei, Seth
Sacarlal, Jahit
Aide, Pedro
Aponte, John J
Dutta, Sheetij
Gyan, Ben
Campo, Joseph J
Valim, Clarissa
Moncunill, Gemma
Dobaño, Carlota
Funding for this research was provided by:
National Institutes of Health (NIH-NIAID (R01AI095789))
PATH Malaria Vaccine Initiative (N/A)
Ministerio de Economía, Industria y Competitividad, Gobierno de España (PI11/00423)
EviMalaR (N/A)
AGAUR-Catalonia (2014 SGR991)
CERCA Program-Generalitat de Catalunya
Article History
Received: 4 July 2018
Accepted: 1 October 2018
First Online: 31 October 2018
Ethics approval and consent to participate
: The study protocol was approved by the Ethics Committees from Spain, Mozambique, and Ghana, and written informed consent was obtained from parents or guardians.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.